What the FDA labels say about taking them together
Atomoxetine and dobutamine
Atomoxetine's FDA label of May 25, 2026 names dobutamine in its drug interactions section; the dobutamine labels PlainMeds reads (2) do not name atomoxetine. The atomoxetine label: “Drugs and Pressor Agents Because of possible effects on blood pressure, atomoxetine should be used cautiously with antihypertensive drugs and pressor agents or other drugs that increase blood pressure.”
Check it at the source: the atomoxetine FDA label on DailyMed (effective May 25, 2026, Camber Pharmaceuticals, Inc.); the dobutamine FDA label on DailyMed (effective June 3, 2026, Hospira, Inc.).
What does the atomoxetine label say about dobutamine?
Atomoxetine label, drug interactionsDrugs and Pressor Agents Because of possible effects on blood pressure, atomoxetine should be used cautiously with antihypertensive drugs and pressor agents (e.g., dopamine, dobutamine) or other drugs that increase blood pressure.
Strattera label (Eli Lilly and Company, June 30, 2026), drug interactionsMechanism and Clinical Effect (s); Because of increased risk of increased blood pressure, STRATTERA should be used cautiously with antihypertensive drugs, other drugs that increase blood pressure or pressor drugs (e.g., dopamine, dobutamine).
Source: FDA drug label (Strattera, NDA021411), Eli Lilly and Company, effective June 30, 2026 (SPL set 309de576-c318-404a-bc15-660c2b1876fb), via openFDA
Source: FDA drug label (Atomoxetine Hydrochloride, NDA220320), Advagen Pharma Ltd., effective April 3, 2026 (SPL set 16096e9c-2dcd-4c84-a1a8-1c85d6d6898c), via openFDA
Source: FDA drug label (Atomoxetine), ANDA202682 (Hetero Labs Ltd V), as published by Camber Pharmaceuticals, Inc., effective May 25, 2026 (SPL set f266ab7b-5a68-42b5-b204-e3249bea0aed), via openFDA; the full label on DailyMed
What does the dobutamine label say about atomoxetine?
Dobutamine's label (effective June 3, 2026) and its 1 other brand-application label do not name atomoxetine in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Dobutamine in Dextrose), Hospira, Inc., effective June 3, 2026 (SPL set 9943a961-3b50-4847-8a84-d8414ce38daa), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Atomoxetine | Dobutamine | |
|---|---|---|
| Labeled for | ADHD | n/a |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $0.442 per capsule 40 mg capsule | n/a |
| Shortage now | No current entry | In shortage |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once